Free Trial
→ Goldman Sachs just told you what to buy (most people missed it) (From Behind the Markets) (Ad)tc pixel Free MCTA Stock Alerts

Charming Medical (MCTA) Competitors

Charming Medical logo
$29.36 -0.01 (-0.02%)
As of 06/10/2026
Compare

MCTA vs. SGRY, ADUS, VRDN, AGL, and SNDA

Should you buy Charming Medical stock or one of its competitors? MarketBeat compares Charming Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Charming Medical include Surgery Partners (SGRY), Addus HomeCare (ADUS), Viridian Therapeutics (VRDN), Agilon Health (AGL), and Sonida Senior Living (SNDA). These companies are all part of the "healthcare" industry.

How does Charming Medical compare to Surgery Partners?

Surgery Partners (NASDAQ:SGRY) and Charming Medical (NASDAQ:MCTA) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings.

Charming Medical has lower revenue, but higher earnings than Surgery Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$3.31B0.59-$77.90M-$0.60N/A
Charming MedicalN/AN/AN/AN/AN/A

In the previous week, Surgery Partners had 1 more articles in the media than Charming Medical. MarketBeat recorded 3 mentions for Surgery Partners and 2 mentions for Charming Medical. Surgery Partners' average media sentiment score of 1.29 beat Charming Medical's score of 0.48 indicating that Surgery Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgery Partners
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Charming Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Charming Medical has a net margin of 0.00% compared to Surgery Partners' net margin of -2.28%. Surgery Partners' return on equity of 1.04% beat Charming Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgery Partners-2.28% 1.04% 0.41%
Charming Medical N/A N/A N/A

Surgery Partners presently has a consensus target price of $22.18, suggesting a potential upside of 48.47%. Given Surgery Partners' stronger consensus rating and higher possible upside, equities research analysts clearly believe Surgery Partners is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.75
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Surgery Partners beats Charming Medical on 9 of the 10 factors compared between the two stocks.

How does Charming Medical compare to Addus HomeCare?

Addus HomeCare (NASDAQ:ADUS) and Charming Medical (NASDAQ:MCTA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.

95.4% of Addus HomeCare shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Addus HomeCare has higher revenue and earnings than Charming Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.42B1.22$95.91M$5.4117.20
Charming MedicalN/AN/AN/AN/AN/A

In the previous week, Charming Medical had 1 more articles in the media than Addus HomeCare. MarketBeat recorded 2 mentions for Charming Medical and 1 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.87 beat Charming Medical's score of 0.48 indicating that Addus HomeCare is being referred to more favorably in the media.

Company Overall Sentiment
Addus HomeCare Very Positive
Charming Medical Neutral

Addus HomeCare has a net margin of 6.89% compared to Charming Medical's net margin of 0.00%. Addus HomeCare's return on equity of 9.80% beat Charming Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare6.89% 9.80% 7.34%
Charming Medical N/A N/A N/A

Addus HomeCare currently has a consensus price target of $131.00, indicating a potential upside of 40.80%. Given Addus HomeCare's stronger consensus rating and higher possible upside, research analysts plainly believe Addus HomeCare is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.70
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Addus HomeCare beats Charming Medical on 11 of the 12 factors compared between the two stocks.

How does Charming Medical compare to Viridian Therapeutics?

Viridian Therapeutics (NASDAQ:VRDN) and Charming Medical (NASDAQ:MCTA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

Charming Medical has lower revenue, but higher earnings than Viridian Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viridian Therapeutics$70.85M23.48-$342.60M-$3.32N/A
Charming MedicalN/AN/AN/AN/AN/A

In the previous week, Viridian Therapeutics had 3 more articles in the media than Charming Medical. MarketBeat recorded 5 mentions for Viridian Therapeutics and 2 mentions for Charming Medical. Charming Medical's average media sentiment score of 0.48 beat Viridian Therapeutics' score of 0.37 indicating that Charming Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Viridian Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Charming Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Viridian Therapeutics presently has a consensus price target of $36.14, suggesting a potential upside of 123.93%. Given Viridian Therapeutics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Viridian Therapeutics is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viridian Therapeutics
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.79
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Charming Medical has a net margin of 0.00% compared to Viridian Therapeutics' net margin of -490.31%. Charming Medical's return on equity of 0.00% beat Viridian Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Viridian Therapeutics-490.31% -80.19% -48.84%
Charming Medical N/A N/A N/A

Summary

Viridian Therapeutics beats Charming Medical on 5 of the 9 factors compared between the two stocks.

How does Charming Medical compare to Agilon Health?

Charming Medical (NASDAQ:MCTA) and Agilon Health (NYSE:AGL) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment and earnings.

In the previous week, Charming Medical and Charming Medical both had 2 articles in the media. Agilon Health's average media sentiment score of 0.81 beat Charming Medical's score of 0.48 indicating that Agilon Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Charming Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Agilon Health
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Charming Medical has higher earnings, but lower revenue than Agilon Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charming MedicalN/AN/AN/AN/AN/A
Agilon Health$5.93B0.32-$391.35M-$21.56N/A

Charming Medical has a net margin of 0.00% compared to Agilon Health's net margin of -6.09%. Charming Medical's return on equity of 0.00% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Charming MedicalN/A N/A N/A
Agilon Health -6.09%-146.03%-24.55%

Agilon Health has a consensus price target of $58.73, suggesting a potential downside of 49.10%. Given Agilon Health's stronger consensus rating and higher possible upside, analysts plainly believe Agilon Health is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Agilon Health
2 Sell rating(s)
8 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.20

Summary

Agilon Health beats Charming Medical on 5 of the 8 factors compared between the two stocks.

How does Charming Medical compare to Sonida Senior Living?

Sonida Senior Living (NYSE:SNDA) and Charming Medical (NASDAQ:MCTA) are both small-cap services companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

Charming Medical has lower revenue, but higher earnings than Sonida Senior Living.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sonida Senior Living$411.85M4.04-$70.78M-$5.83N/A
Charming MedicalN/AN/AN/AN/AN/A

In the previous week, Charming Medical had 2 more articles in the media than Sonida Senior Living. MarketBeat recorded 2 mentions for Charming Medical and 0 mentions for Sonida Senior Living. Sonida Senior Living's average media sentiment score of 0.92 beat Charming Medical's score of 0.48 indicating that Sonida Senior Living is being referred to more favorably in the media.

Company Overall Sentiment
Sonida Senior Living Positive
Charming Medical Neutral

87.6% of Sonida Senior Living shares are owned by institutional investors. 39.3% of Sonida Senior Living shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Charming Medical has a net margin of 0.00% compared to Sonida Senior Living's net margin of -24.15%. Charming Medical's return on equity of 0.00% beat Sonida Senior Living's return on equity.

Company Net Margins Return on Equity Return on Assets
Sonida Senior Living-24.15% -36.98% -7.08%
Charming Medical N/A N/A N/A

Sonida Senior Living currently has a consensus target price of $40.50, indicating a potential upside of 15.31%. Given Sonida Senior Living's stronger consensus rating and higher possible upside, analysts plainly believe Sonida Senior Living is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonida Senior Living
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Sonida Senior Living beats Charming Medical on 7 of the 11 factors compared between the two stocks.

Get Charming Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MCTA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MCTA vs. The Competition

Export
MetricCharming MedicalServices – Health IndustryServices SectorNASDAQ Exchange
Market Cap$497.21M$1.57B$962.25M$11.73B
Dividend YieldN/AN/A4.80%5.56%
P/E RatioN/A15.1111.1724.35
Price / SalesN/A5.8046.81117.06
Price / CashN/A3,057.15347.1454.62
Price / BookN/A37.4011.346.82
Net IncomeN/A-$26.94M-$12.37M$337.41M
7 Day PerformanceN/A1.35%0.88%2.49%
1 Month Performance-0.02%-2.54%-6.51%3.69%
1 Year PerformanceN/AN/A49.57%27.72%

Charming Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MCTA
Charming Medical
N/A$29.36
0.0%		N/AN/A$497.21MN/AN/A49
SGRY
Surgery Partners
3.9332 of 5 stars		$13.96
+0.8%		$22.18
+58.9%		-35.5%$1.81B$3.31BN/A16,000
ADUS
Addus HomeCare
4.095 of 5 stars		$92.70
+2.2%		$131.00
+41.3%		-17.4%$1.69B$1.42B17.1350,659
VRDN
Viridian Therapeutics
3.6179 of 5 stars		$16.31
+3.7%		$36.14
+121.6%		+0.3%$1.62B$70.85MN/A50
AGL
Agilon Health
1.633 of 5 stars		$101.74
+6.7%		$58.73
-42.3%		+102.0%$1.59B$5.93BN/A1,076

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:MCTA) was last updated on 6/12/2026 by MarketBeat.com Staff.
From Our Partners
Is your wealth prepared for “America’s Most Dangerous Man”? (Read before June 16)
60-year Wall Street veteran Marc Chaikin is issuing an urgent warning about the billionaire behind an AI lab t...
Chaikin Analytics | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
The chokepoint supplier behind SpaceX's $1.75 trillion empire
When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession...
Behind the Markets | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
This Is How Financial Freedom Dies—And Most People Never See It Coming
While the trade war grabs headlines, the Department of Justice has quietly argued in court that cash may not b...
Priority Gold | Sponsoredtc pixel
Jon Najarian: “Make this move now that SPCX is trading”
SpaceX is now publicly trading under the ticker SPCX - but Hall of Fame Trader Jon Najarian says the real oppo...
Banyan Hill Publishing | Sponsoredtc pixel